October 6, 2025- InspiroGene™ by McKesson announced the publication of its second annual 2025 Cell and Gene Therapy Report: Advancing the Future of Medicine. Drawing on new insights from research with physicians and payers; an updated analysis of the U.S. CGT pipeline; and an analysis of all the U.S. sites of care where CGTs are administered, this year’s report illustrates that these ground-breaking medicines are steadily becoming more available to patients, but are still facing systemic hurdles slowing widespread adoption.
The report showcases a newly refreshed interactive map of qualified CGT treatment centers nationwide, along with exclusive insights from leading industry experts.
The full 2025 Cell and Gene Therapy Report can be found at www.inspirogene.com/cgt-report.
Continue Reading here for key findings of the report.